September brought another research update from Metagenics, and one item stood out for the women who visit the clinic: a trial carried out after menopause.
In that study, published in the journal Gut Microbes in 2026, postmenopausal women took pasteurised Akkermansia muciniphila MucT, a gut bacterium in inactive form, for four months. The researchers examined insulin sensitivity, the gut hormone GLP-1 and some kidney function markers. Metagenics notes that the picture differed according to how much Akkermansia each woman had to begin with, which is a reminder that people respond differently.
A single study in one group cannot tell us what an individual needs. At the clinic, acupuncture and herbal care are planned around your own history, and any supplement idea is talked through with you, slowly, and with your doctor's knowledge.
The same update contained material meant only for practitioners, including a protocol about GLP-1 medicines. If you are prescribed one of these medicines, your doctor remains the person to guide any change.
Metagenics sells MucT within its UltraFlora range, available through the clinic group's Healthy Market.
If this raises questions for you, bring them to your next consultation with Dr Christine Shen, Acupuncturist. Bookings: 0410 699 065.
Copyright© 2002-2026 visuallink© SaaS - Web Hosted Solutions, Design and Maintenance by Visual Link IT Pty Ltd - Software Solutions
Comments are disabled